Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors
Conditions
Advanced Solid Tumors
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of California San Diego, San Diego, California, United States
Sarcoma Oncology Center, Santa Monica, California, United States
Moffitt Cancer Center, Tampa, Florida, United States
University of Chicago, Chicago, Illinois, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
University of Pennsylvania, Philadelphia, Pennsylvania, United States
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
University of Texas - M.D. Anderson Cancer Center, Houston, Texas, United States
NEXT Oncology Houston, Houston, Texas, United States
NEXT Virginia, Fairfax, Virginia, United States
Hopital Saint - Andre - CHU de Bordeaux, Bordeaux, France
Centre Léon Bérard, Lyon, France
Hôpital de la Timone, Marseille, France
Hospital Universitario Vall d'Hebron, Barcelona, Spain
Hospital Universitario Ramón y Cajal, Madrid, Spain
START Madrid - Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
Hospital Universitario 12 de Octubre, Madrid, Spain
Hospital Clínico Universitario de Valencia, Valencia, Spain